Literature DB >> 2167725

Role of the semi-quinone free radical of the anti-tumour agent etoposide (VP-16-213) in the inactivation of single- and double-stranded phi X174 DNA.

D R Mans1, J Retèl, J M van Maanen, M V Lafleur, M A van Schaik, H M Pinedo, J Lankelma.   

Abstract

The mechanism of action of the anti-tumour agent etoposide (VP-16-213) could involve its bioactivation to metabolites which can damage DNA. Active metabolites of etoposide, generated in vitro, are the 3',4'-dihydroxy-derivative (catechol) and its oxidation product, the ortho-quinone. The conversion of the catechol into the ortho-quinone (and vice versa) proceeds via formation of a semi-quinone free radical. We investigated the role of this radical species in the inactivation of biologically active single- (ss) and double-stranded (RF) phi X174 DNA. Since the formation of semi-quinone free radicals from the ortho-quinone of etoposide is pH dependent, experiments were performed, in which the ortho-quinone was incubated at pH 4, 7.4 and greater than or equal to 9. ESR measurements showed no formation of radical species from the ortho-quinone at pH 4, but an increased rate of generation of the primary semi-quinone free radical at pH values 7.4 to 10; at still higher pH values a secondary semi-quinone free radical was produced. HPLC analyses demonstrated chemical stability of the ortho-quinone at pH 4, but an accelerated decay was observed when the pH was elevated from 7.4 to 9, with its concomitant conversion into more polar components and into the catechol of etoposide. Ss phi X174 DNA, exposed to the ortho-quinone, was inactivated at an increasing rate at pH values increasing from 4 to 7.4 and subsequently to 9. RF phi X174 DNA was only significantly inactivated in incubations with the ortho-quinone at pH 4, not at pH values 7.4 and 9. From these data it is concluded that the primary semi-quinone free radical of etoposide may to a great extent be responsible for the ortho-quinone-induced ss phi X174 DNA inactivation, but that this radical species is not lethal towards RF phi X174 DNA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167725      PMCID: PMC1971739          DOI: 10.1038/bjc.1990.228

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  Effect of VP-16-213 on the intracellular degradation of DNA in HeLa cells.

Authors:  J D Loike; S B Horwitz
Journal:  Biochemistry       Date:  1976-12-14       Impact factor: 3.162

2.  Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II.

Authors:  G L Chen; L Yang; T C Rowe; B D Halligan; K M Tewey; L F Liu
Journal:  J Biol Chem       Date:  1984-11-10       Impact factor: 5.157

3.  Construction of viable and lethal mutations in the origin of bacteriophage 'phi' X174 using synthetic oligodeoxyribonucleotides.

Authors:  P D Baas; W R Teertstra; A D van Mansfeld; H S Jansz; G A van der Marel; G H Veeneman; J H van Boom
Journal:  J Mol Biol       Date:  1981-11-15       Impact factor: 5.469

4.  DNA damage as a basis for 4'-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucopyranoside) (etoposide) cytotoxicity.

Authors:  A J Wozniak; W E Ross
Journal:  Cancer Res       Date:  1983-01       Impact factor: 12.701

5.  Characterization of VP-16-induced DNA damage in isolated nuclei from L1210 cells.

Authors:  B S Glisson; S E Smallwood; W E Ross
Journal:  Biochim Biophys Acta       Date:  1984-10-05

6.  The radiosensitivity of bacteriophage DNA in aqueous solution.

Authors:  J Blok; L H Luthjens; A L Roos
Journal:  Radiat Res       Date:  1967-03       Impact factor: 2.841

7.  Characterization of free radicals produced during oxidation of etoposide (VP-16) and its catechol and quinone derivatives. An ESR Study.

Authors:  B Kalyanaraman; J Nemec; B K Sinha
Journal:  Biochemistry       Date:  1989-05-30       Impact factor: 3.162

8.  Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationship.

Authors:  B H Long; S T Musial; M G Brattain
Journal:  Biochemistry       Date:  1984-03-13       Impact factor: 3.162

9.  Potentiation of etoposide-induced DNA damage by calcium antagonists in L1210 cells in vitro.

Authors:  J C Yalowich; W E Ross
Journal:  Cancer Res       Date:  1984-08       Impact factor: 12.701

10.  Inhibition of etoposide-induced DNA damage and cytotoxicity in L1210 cells by dehydrogenase inhibitors and other agents.

Authors:  A J Wozniak; B S Glisson; K R Hande; W E Ross
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

View more
  6 in total

Review 1.  Interactions between antiretrovirals and antineoplastic drug therapy.

Authors:  Tony Antoniou; Alice L Tseng
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.

Authors:  B D Lovett; L Lo Nigro; E F Rappaport; I A Blair; N Osheroff; N Zheng; M D Megonigal; W R Williams; P C Nowell; C A Felix
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

3.  Association of CYP3A4 genotype with treatment-related leukemia.

Authors:  C A Felix; A H Walker; B J Lange; T M Williams; N J Winick; N K Cheung; B D Lovett; P C Nowell; I A Blair; T R Rebbeck
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

4.  Combination toxicity of etoposide (VP-16) and photosensitisation with a water-soluble aluminium phthalocyanine in K562 human leukaemic cells.

Authors:  T G Gantchev; N Brasseur; J E van Lier
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

5.  Design and synthesis of novel isoxazole tethered quinone-amino Acid hybrids.

Authors:  P Ravi Kumar; Manoranjan Behera; M Sambaiah; Venu Kandula; Nagaraju Payili; A Jaya Shree; Satyanarayana Yennam
Journal:  J Amino Acids       Date:  2014-11-19

6.  Oral treatment with etoposide in small cell lung cancer - dilemmas and solutions.

Authors:  Renata Rezonja; Lea Knez; Tanja Cufer; Ales Mrhar
Journal:  Radiol Oncol       Date:  2013-02-01       Impact factor: 2.991

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.